KARMA YOUNGSTROM: Open Payments
NPI 1093186280 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,802 in 98 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $950 · 2025 $1,802
Food & beverage: $1,802
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $357 |
| ABBVIE INC. | 23 | $267 |
| PFIZER INC. | 10 | $247 |
| Phathom Pharmaceuticals, Inc. | 9 | $192 |
| Janssen Biotech, Inc. | 4 | $95 |
| Madrigal Pharmaceuticals | 3 | $93 |
| Regeneron Healthcare Solutions, Inc. | 5 | $85 |
| GENZYME CORPORATION | 4 | $62 |
| Aimmune Therapeutics, Inc. | 3 | $51 |
| Ardelyx, Inc. | 2 | $44 |
Products named: ENTYVIO, RINVOQ, VOQUEZNA, VELSIPITY, DUPIXENT, TREMFYA, REZDIFFRA, EOHILIA.
Industry payments across ID — which companies pay providers there.
